1. All of the following are important issues in study design and ultimate clinical utility for pharmacological agents used to treat acute severe hypertension with end-organ damage except:

2. JW is a 56-year-old male presenting to the emergency department with chief complaint of left-sided weakness and difficulty speaking. Patient has a past medical history of hypertension and hyperlipidemia but takes no medications. Vital signs on admission include a blood pressure 225/111, HR 86 beats per minute, respiratory rate of 32 breaths per minute, and O2 sat of 96% on room air. A STAT head CT shows evidence of an acute intracerebral hemorrhage. Which of the following statements is correct?

3. After his CT scan, JW returns to the emergency department. His nurse measures a repeat blood pressure and informs you that the blood pressure is now 225/114 mmHg. Which of the following is the most appropriate anti-hypertensive agent to administer for acute blood pressure control?

4. Which of the following agents would be most appropriate to initiate in a patient presenting to your hospital with Acute Severe Hypertension (BP 210/118) manifesting as acute pulmonary edema due to acute heart failure exacerbation?

5. Pharmacist involvement in care of patients who are critically ill or experiencing medical emergencies has been demonstrated to achieve which of the following:

« Return to Activity